Compare · NRC vs OABI
NRC vs OABI
Side-by-side comparison of NRC Health (NRC) and OmniAb Inc. (OABI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NRC and OABI operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- OABI is the larger of the two at $716.2M, about 1.3x NRC ($563.6M).
- NRC has been more active in the news (7 items in the past 4 weeks vs 5 for OABI).
- OABI has more recent analyst coverage (5 ratings vs 1 for NRC).
- Company
- NRC Health
- OmniAb Inc.
- Price
- -
- -
- Market cap
- $563.6M
- $716.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 7
- 5
- Recent ratings
- 1
- 5
NRC Health
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Latest NRC
- EVP & Chief Operating Officer Hrdy Helen exercised 12,619 shares at a strike of $18.80 and covered exercise/tax liability with 10,491 shares, increasing direct ownership by 2% to 142,646 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by NRC Health
- SEC Form 10-Q filed by NRC Health
- SEC Form 8-K filed by NRC Health
- NRC Health Announces Third Quarter 2026 Results
- NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
- SEC Form 8-K filed by NRC Health
- New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
- The Governance Institute Blue Ribbon Committee Reframes Hospital and Health System Board Assessment with Four Considerations for Stronger Governance
- KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
Latest OABI
- Director Love Steven converted options into 13,334 shares, increasing direct ownership by 15% to 105,000 units (SEC Form 4)
- SEC Form 10-Q filed by OmniAb Inc.
- OmniAb Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights
- OmniAb to Participate in Upcoming Investor Conferences in November
- OmniAb to Report Third Quarter 2026 Financial Results on October 30
- OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
- OmniAb to Host Investor & Analyst Day on October 6, 2026
- OmniAb to Participate in Upcoming Investor Conferences
- OmniAb Raises 2026 Financial Guidance